Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112239436A details a novel Pd-catalyzed bis-carbonylation route for 4-acyl-2(5H)-furanones, offering high yields and simplified supply chains for API manufacturing.
Patent CN112694430B reveals a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one intermediates, offering high efficiency and substrate compatibility for API manufacturing.
Novel Pt/C-catalyzed method enables scalable production of high-purity pharmaceutical intermediates with simplified purification and substantial cost reduction potential.
Discover how glucose-based synthesis of 3-trifluoromethyl-1,2,4-triazole eliminates anhydrous/oxygen-free requirements, cuts production costs, and ensures 99% purity for pharmaceutical intermediates.
Eliminate explosive peroxide risks in 5-trifluoromethyl-1,2,4-triazole synthesis. Our elemental sulfur-promoted method offers scalable, anhydrous-free production for pharma intermediates. Reduce costs and supply chain risks.
Solve low yield & high cost in fexuprazan intermediate production. New route with >50% yield, 50% cost reduction. Scale to 100MT/yr.
Discover how metal-free diselenomaleimide synthesis at room temperature reduces production costs and supply chain risks for pharmaceutical intermediates. High-yield, scalable solution for R&D and procurement teams.
Discover how this metal-free synthesis of 3-ethynyl imidazo[1,2-b]pyridazine reduces 8-step routes to 2 steps, cutting costs and eliminating metal residues for BCR-ABL kinase inhibitor manufacturing.
Discover catalyst-free oxadiazaborole synthesis with 5-min reaction time and >80% yield. Ideal for pharmaceutical intermediates with simplified purification and scalable production.
Discover a metal-free, low-cost synthesis method for 5-trifluoromethyl-1,2,4-triazole compounds. Eliminate heavy metal catalysts and reduce supply chain risks for your API manufacturing.
Solve heavy metal contamination risks in quinoline synthesis. Our metal-free, air-stable process cuts costs & ensures GMP compliance for API manufacturing.
Eliminate explosive peroxides and heavy metals in 1,2,4-triazole synthesis. Our CDMO expertise scales this sulfur-promoted method for high-purity API intermediates with 99%+ purity.
Discover a one-step Pd-catalyzed synthesis of 1,5-dihydro-2H-pyrrole-2-ketone with 70-92% yield. Eliminate multi-step processes and supply chain risks for API intermediates.
Discover how this novel palladium-catalyzed route to 3-arylquinoline-2(1H) ketone derivatives reduces production costs by 30% while maintaining >99% purity for API manufacturing.
Discover how this novel bromine-free route eliminates unstable reagents, reduces production costs, and ensures consistent supply for your bronchodilator manufacturing.
Discover how rhodium-catalyzed C-H activation enables high-yield trifluoromethyl enamine synthesis with 80%+ yields, reducing supply chain risks for drug development.
Eliminate heavy metal catalysts and complex steps in 1,2,4-triazole synthesis. Our CDMO expertise ensures scalable production of high-purity intermediates for drug development.
Discover how new asymmetric synthesis of (S,S)-2,8-diazabicyclononane reduces costs and steps for moxifloxacin production, ensuring supply chain stability.
Discover how novel nintedanib synthesis routes with 92% yield and mild conditions reduce production costs by 30% while ensuring GMP compliance for IPF treatment.
Solve toxic reagent risks in phenanthridinone production. Discover 1 atm CO pressure process for high-yield, scalable API intermediates with reduced supply chain risks.